January 2022 FDA Recall Drug by Vistapharm, Inc.
D-0376-2022 - Failed Stability Specifications

This Class II drug recall was voluntarily initiated by Vistapharm, Inc. on January 7, 2022 for the product Drug. The FDA reported the reason for recall as failed stability specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0376-2022

Reason for Recall
Failed Stability Specifications
Initiated
01-07-2022
Reported
01-26-2022
Quantity
18,456 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide within the United States including Puerto Rico
Clobazam Oral Suspension 2.5 mg/mL, 120 mL bottles, Rx only, Manufactured by: VistaPharm, Inc. Largo, FL 33771, NDC 66689-058-04

Batch or Lot Expiration Information

Lot# Lots #: 678900, 682000, 682400, Exp. 5/31/2022; 680600, 680800, 681000 Exp. 5/30/2022; 683200, 685200 Exp. 6/30/2022; 728900, 733100 Exp. Date 12/31/2022; 738600 Exp. 1/31/2023; 740600, 741600 Exp. 2/28/2023; 749800, 750900, 752400 Exp. 3/31/2023; 775700 Exp. 6/30/2023